Literature DB >> 11912294

Clinical advantages of new peritoneal dialysis solutions.

Raymond T Krediet1, Roos van Westrhenen, Machteld M Zweers, Dirk G Struijk.   

Abstract

A review is given of the various mechanisms by which conventional glucose/lactate-based peritoneal dialysis solutions can induce damage to the peritoneal membrane. The potential advantages of newly developed dialysis solutions and the results of recent studies on their use in patients are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912294     DOI: 10.1093/ndt/17.suppl_3.16

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

Review 1.  Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients.

Authors:  Raymond T Krediet; Alena Parikova
Journal:  Clin J Am Soc Nephrol       Date:  2022-02-15       Impact factor: 10.614

Review 2.  Aging of the Peritoneal Dialysis Membrane.

Authors:  Raymond T Krediet
Journal:  Front Physiol       Date:  2022-04-28       Impact factor: 4.755

Review 3.  Peritoneal changes in patients on long-term peritoneal dialysis.

Authors:  Raymond T Krediet; Dirk G Struijk
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

Review 4.  Icodextrin: a review of its use in peritoneal dialysis.

Authors:  James E Frampton; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  New Insights into the Effects of Chronic Kidney Failure and Dialysate Exposure on the Peritoneum.

Authors:  Carmen A Vlahu; Jan Aten; Marijke de Graaff; Henk van Veen; Vincent Everts; Dirk R de Waart; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2016-05-04       Impact factor: 1.756

6.  Peritoneal dialysis: from bench to bedside.

Authors:  Raymond T Krediet
Journal:  Clin Kidney J       Date:  2013-10-14

7.  Acquired Decline in Ultrafiltration in Peritoneal Dialysis: The Role of Glucose.

Authors:  Raymond T Krediet
Journal:  J Am Soc Nephrol       Date:  2021-07-28       Impact factor: 14.978

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.